Slivka S R, Godson C, Insel P A
Department of Pharmacology, University of California, San Diego, La Jolla 92093.
J Cell Biochem. 1990 Feb;42(2):59-70. doi: 10.1002/jcb.240420202.
The results of studies to evaluate the hypothesis that the 21 kDa GTP-binding protein derived from the ras oncogene is involved in regulation and coupling of hormone receptors to phospholipase activity have thus far been inconsistent. We therefore examined the effect of H-ras transformation on basal, tumor-promoting phorbol ester (TPA)-stimulated, and bradykinin-mediated phospholipid hydrolysis in Madin Darby canine kidney cells (MDCK) by comparing H-ras-transformed MDCK cells (MDCK-RAS) to two non-transformed strains of MDCK cells (MDCK-D1 and MDCK-ATCC). In unstimulated MDCK-RAS, diacylglycerol (DAG), inositol phosphate accumulation, and choline phosphate release were increased while arachidonic acid and arachidonic acid metabolite (AA) release was not increased, suggesting that ras transformation increased phospholipase C activity. Protein kinase C (PK-C) activity was decreased, and specific binding of [3H]phorbol ester was reduced in MDCK-RAS relative to the non-transformed MDCK cells suggesting that elevated DAG may activate and thereby down-regulate PK-C. Consistent with this finding in MDCK-RAS, TPA-stimulated AA release and subsequent prostaglandin E2 production were decreased, while TPA-stimulated choline phosphate release was increased. Bradykinin receptor-stimulated phospholipid hydrolysis in MDCK-RAS was similar to that of non-transformed cells, suggesting that the ras-derived protein does not directly couple bradykinin receptors to phospholipases in MDCK cells. However, the ability of TPA-treatment to inhibit bradykinin-stimulated phosphoinositide hydrolysis and enhance bradykinin-stimulated AA release was attenuated in MDCK-RAS. Additionally, in MDCK-RAS the conversion of arachidonic acid to prostaglandin E2 was substantially reduced. We conclude that ras transformation of MDCK cells increases DAG levels, thereby activating and, in turn, down-regulating PK-C and certain responses to TPA. Since activation of PK-C may result in a variety of effects on signal transduction pathways, we propose that increased DAG and altered PK-C levels associated with ras transformation may account for the inconsistent effects previously observed in studies evaluating the effect of ras transformation on phospholipases and other signal transduction systems.
评估源自ras癌基因的21 kDa GTP结合蛋白参与激素受体与磷脂酶活性的调节和偶联这一假说的研究结果迄今并不一致。因此,我们通过将H-ras转化的Madin Darby犬肾细胞(MDCK)(MDCK-RAS)与两种未转化的MDCK细胞系(MDCK-D1和MDCK-ATCC)进行比较,研究了H-ras转化对基础的、促肿瘤的佛波酯(TPA)刺激的以及缓激肽介导的MDCK细胞磷脂水解的影响。在未刺激的MDCK-RAS中,二酰基甘油(DAG)、肌醇磷酸积累和胆碱磷酸释放增加,而花生四烯酸和花生四烯酸代谢物(AA)释放未增加,这表明ras转化增加了磷脂酶C活性。与未转化的MDCK细胞相比,MDCK-RAS中的蛋白激酶C(PK-C)活性降低,[3H]佛波酯的特异性结合减少,这表明升高的DAG可能激活并由此下调PK-C。与MDCK-RAS中的这一发现一致,TPA刺激的AA释放及随后的前列腺素E2生成减少,而TPA刺激的胆碱磷酸释放增加。MDCK-RAS中缓激肽受体刺激的磷脂水解与未转化细胞相似,这表明源自ras的蛋白不会直接将缓激肽受体与MDCK细胞中的磷脂酶偶联。然而,在MDCK-RAS中,TPA处理抑制缓激肽刺激的磷酸肌醇水解并增强缓激肽刺激的AA释放的能力减弱。此外,在MDCK-RAS中,花生四烯酸向前列腺素E2的转化大幅减少。我们得出结论,MDCK细胞的ras转化增加了DAG水平,从而激活并进而下调PK-C以及对TPA的某些反应。由于PK-C的激活可能对信号转导途径产生多种影响,我们提出与ras转化相关的DAG增加和PK-C水平改变可能解释了先前在评估ras转化对磷脂酶和其他信号转导系统影响的研究中观察到的不一致效应。